NDC 80735-820
Zemdri (plazomicin)
Plazomicin
Zemdri (plazomicin) is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cipla Therapeutics Inc.. The primary component is Plazomicin.
| Product ID | 80735-820_1ceb0ab0-453c-4aba-99a4-504161ba658c |
| NDC | 80735-820 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zemdri (plazomicin) |
| Generic Name | Plazomicin |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-07-16 |
| Marketing Category | NDA / |
| Application Number | NDA210303 |
| Labeler Name | Cipla Therapeutics Inc. |
| Substance Name | PLAZOMICIN |
| Active Ingredient Strength | 500 mg/10mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |